Search

Your search keyword '"Yamamoto, Yoshiya"' showing total 381 results
Start Over Author "Yamamoto, Yoshiya"
381 results on '"Yamamoto, Yoshiya"'

51. Electronic and crystal structures of LnFeAsO1−x H x(Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction (part I: carrier-doping dependence)

Author

Yamamoto, Yoshiya, primary, Yamaoka, Hitoshi, additional, Uozumi, Takayuki, additional, Hariki, Atsushi, additional, Onari, Seiichiro, additional, Yamaura, Jun-ichi, additional, Ishii, Kenji, additional, Kawai, Takuma, additional, Yoshida, Masahiro, additional, Taguchi, Munetaka, additional, Kobayashi, Kensuke, additional, Lin, Jung-Fu, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, Okanishi, Hiroshi, additional, Iimura, Soshi, additional, Matsuishi, Satoru, additional, Hosono, Hideo, additional, and Mizuki, Jun’ichiro, additional

Published
2021
Full Text
View/download PDF

52. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

Author

Chuma, Makoto, Hige, Shuhei, Kamiyama, Toshiya, Meguro, Takashi, Nagasaka, Atsushi, Nakanishi, Kazuaki, Yamamoto, Yoshiya, Nakanishi, Mitsuru, Kohara, Toshihisa, Sho, Takuya, Yamamoto, Keiko, Horimoto, Hiromasa, Kobayashi, Tomoe, Yokoo, Hideki, Matsushita, Michiaki, Todo, Satoru, and Asaka, Masahiro

Published
2009
Full Text
View/download PDF

56. Genomic Profiling of Small Superficial Non-Ampullary Duodenal Epithelial Tumors

Author

Miyamoto, Shuichi, primary, Suda, Goki, additional, Ishikawa, Marin, additional, Hayashi, Hideyuki, additional, Nimura, Satoshi, additional, Matsuno, Yoshihiro, additional, Mori, Ryo, additional, Tanishima, Shigeki, additional, Kudo, Takahiko, additional, Takagi, Tomofumi, additional, Yamamoto, Yoshiya, additional, Ono, Shoko, additional, Shimizu, Yuichi, additional, and Sakamoto, Naoya, additional

Published
2021
Full Text
View/download PDF

57. Very urgent endoscopic retrograde cholangiopancreatography is associated with early discharge in patients with non-severe acute cholangitis

Author

Sugiura, Ryo, primary, Naruse, Hirohito, additional, Yamamoto, Yoshiya, additional, Hatanaka, Kazuteru, additional, Kinoshita, Kenji, additional, Abiko, Satoshi, additional, Miyamoto, Shuichi, additional, Suzuki, Kazuharu, additional, Higashino, Masayuki, additional, Kohya, Risako, additional, and Sakamoto, Naoya, additional

Published
2021
Full Text
View/download PDF

58. Additional file 1 of Delay in seeking treatment before emergent heart failure readmission and its association with clinical phenotype

Author

Takei, Makoto, Harada, Kazumasa, Shiraishi, Yasuyuki, Matsuda, Junya, Iwasaki, Yoichi, Yamamoto, Yoshiya, Matsushita, Kenichi, Miyazaki, Tetsuro, Miyamoto, Takamichi, Kiyosi Iida, Tanimoto, Shuzo, Nagatomo, Yuji, Hosoda, Toru, Kohsaka, Shun, Yamamoto, Takeshi, Nagao, Ken, and Takayama, Morimasa

Abstract

Additional file 1: Supplemental Figure 1. Distribution of time interval between symptom onset and the time patients asked for emergency medical services. n = 1173 (time interval

Published
2020
Full Text
View/download PDF

59. Electronic and crystal structures of (Na1−xCax)Cr2O4 with anomalous colossal magnetoresistance

Author

Yamaoka, Hitoshi, primary, Schwier, Eike F., additional, Yamamoto, Yoshiya, additional, Nakatake, Masashi, additional, Sawada, Masahiro, additional, Sakurai, Hiroya, additional, Tsujii, Naohito, additional, Arita, Masashi, additional, Iwasawa, Hideaki, additional, Taguchi, Munetaka, additional, Shimada, Kenya, additional, and Mizuki, Jun'ichiro, additional

Published
2020
Full Text
View/download PDF

63. Efficacy of therapy for advanced hepatocellular carcinoma: Intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation

Author

Chuma, Makoto, Taguchi, Hiroshi, Yamamoto, Yoshiya, Shimizu, Shinichi, Nakanishi, Mitsuru, Ogawa, Koji, Sho, Takuya, Horimoto, Hiromasa, Kobayashi, Tomoe, Nakai, Masato, Terashita, Katsumi, Sakuhara, Yusuke, Abo, Daisuke, Tsukuda, Yoko, Tsunematsu, Seiji, Hige, Shuhei, Kato, Mototsugu, Shirato, Hiroki, and Asaka, Masahiro

Published
2011
Full Text
View/download PDF

64. Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria

Author

Sho, Takuya, primary, Suda, Goki, additional, Ogawa, Koji, additional, Shigesawa, Taku, additional, Suzuki, Kazuharu, additional, Nakamura, Akihisa, additional, Ohara, Masatsugu, additional, Umemura, Machiko, additional, Kawagishi, Naoki, additional, Natsuizaka, Mitsuteru, additional, Nakai, Masato, additional, Morikawa, Kenichi, additional, Furuya, Ken, additional, Baba, Masaru, additional, Ito, Jun, additional, Yamamoto, Yoshiya, additional, Kobayashi, Tomoe, additional, Meguro, Takashi, additional, Saga, Akiyoshi, additional, Miyagishima, Takuto, additional, Terasita, Katsumi, additional, Takagi, Tomofumi, additional, Kamiyama, Toshiya, additional, Taketomi, Akinobu, additional, and Sakamoto, Naoya, additional

Published
2020
Full Text
View/download PDF

66. Pressure and Temperature Evolution of Sm Mean-Valence in Golden SmS

Author

Imura, Keiichiro, primary, Suzuki, Yo, additional, Kawade, Naoya, additional, Sakamoto, Kazushi, additional, Deguchi, Kazuhiko, additional, Yamaoka, Hitoshi, additional, Yamamoto, Yoshiya, additional, Mizuki, Jun’ichiro, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Suzuki, Hiroyuki S., additional, and Sato, Noriaki K., additional

Published
2020
Full Text
View/download PDF

69. CLINICAL IMPACT OF HEMODIALYSIS ON SHORT-TERM PROGNOSIS IN ACUTE HEART FAILURE: MULTI-CENTER REGISTRY FROM TOKYO CARDIOVASCULAR CARE UNIT NETWORK

Author

Shindo, Akito, primary, Yamasaki, Masao, additional, Jimba, Takahiro, additional, Nakano, Hiroki, additional, Tsukamoto, Shigeto, additional, Kodera, Satoshi, additional, Matsuda, Junya, additional, Takei, Makoto, additional, Shiraishi, Yasuyuki, additional, Matsushita, Kenichi, additional, Iida, Kiyoshi, additional, Miyamoto, Takamichi, additional, Yamamoto, Yoshiya, additional, Iwasaki, Yoichi, additional, Miyazaki, Tetsuro, additional, Kohsaka, Shun, additional, Koba, Shinji, additional, Takemura, Kazunori, additional, Harada, Kazumasa, additional, Nagao, Ken, additional, Yamamoto, Takeshi, additional, and Takayama, Morimasa, additional

Published
2020
Full Text
View/download PDF

70. IFN-λ3 as a host immune response in acute hepatitis E virus infection

Author

Murata, Kazumoto, primary, Kang, Jong-Hon, additional, Nagashima, Shigeo, additional, Matsui, Takeshi, additional, Karino, Yoshiyasu, additional, Yamamoto, Yoshiya, additional, Atarashi, Tomofumi, additional, Oohara, Masatsugu, additional, Uebayashi, Minoru, additional, Sakata, Hidekatsu, additional, Matsubayashi, Keiji, additional, Takahashi, Kazuaki, additional, Arai, Masahiro, additional, Mishiro, Shunji, additional, Sugiyama, Masaya, additional, Mizokami, Masashi, additional, and Okamoto, Hiroaki, additional

Published
2020
Full Text
View/download PDF

72. Reply to: Heart Failure With Preserved Ejection Fraction in Older Adults

Author

Matsushita, Kenichi, primary, Harada, Kazumasa, additional, Miyazaki, Tetsuro, additional, Miyamoto, Takamichi, additional, Kohsaka, Shun, additional, Iida, Kiyoshi, additional, Yamamoto, Yoshiya, additional, Nagatomo, Yuji, additional, Yoshino, Hideaki, additional, Yamamoto, Takeshi, additional, Nagao, Ken, additional, and Takayama, Morimasa, additional

Published
2019
Full Text
View/download PDF

74. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x- ray diffraction (part I: carrier-doping dependence)

Author

Yamamoto, Yoshiya, Yamaoka, Hitoshi, Uozumi, Takayuki, Hariki, Atsushi, Onari, Seiichiro, Jun-ichi, Yamaura, Ishii, Kenji, Kawai, Takuma, Yoshida, Masahiro, Taguchi, Munetaka, Kobayashi, Kensuke, Jung-Fu, Lin, Hiraoka, Nozomu, Ishii, Hirofumi, Ku-DIng, Tsuei, Okanishi, Hiroshi, Iimura, Soshi, Matsuishi, Satoru, Hosono, Hideo, Jun'ichiro, Mizuki, Kenji, Ishii, and Junichiro, Mizuki

Abstract

A carrier doping by a hydrogen substitution in LaFeAsO1−xHx is known to cause two superconducting (SC) domes with the magnetic order at both end sides of the doping. In contrast, SmFeAsO1−xHx has a similar phase diagram but shows single SC dome. Here, we investigated the electronic and crystal structures for iron oxynitride LnFeAsO1−xHx (Ln = La, Sm) with the range of x = 0-0.5 by using x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction. For both compounds, we observed that the pre-edge peaks of x-ray absorption spectra near the Fe-K edge were reduced in intensity on doping. The character arises from the weaker As–Fe hybridization with the longer As–Fe distance in the higher doped region. We can reproduce the spectra near the Fe-K edge according to the Anderson impurity model with realistic valence structures using the local-density approximation (LDA) plus dynamical mean-field theory (DMFT). For Ln = Sm, the integrated-absolute difference (IAD) analysis from x-ray Fe-Kβ emission spectra increases significantly. This is attributed to the enhancement of magnetic moment of Fe 3d electrons stemming from the localized picture in the higher doped region. A theoretical simulation implementing the self-consistent vertex-correction method reveals that the single dome superconducting phase for Ln = Sm arises from a better nesting condition in comparison with Ln = La.

Published
2021

75. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x- ray diffraction: II pressure dependence

Author

Yamamoto, Yoshiya, Yamaoka, Hitoshi, Yoshida, Masahiro, Jun-ichi, Yamaura, Ishii, Kenji, Onari, Seiichiro, Uozumi, Takayuki, Hariki, Atsushi, Kawai, Takuma, Taguchi, Munetaka, Kobayashi, Kensuke, Jung-Fu, Lin, Hiraoka, Nozomu, Ishii, Hirofumi, Ku-DIng, Tsuei, Okanishi, Hiroshi, Iimura, Soshi, Matsuishi, Satoru, Hosono, Hideo, Jun'ichiro, Mizuki, Kenji, Ishii, and Junichiro, Mizuki

Abstract

We examine electronic and crystal structures of iron-based superconductors LnFeAsO1−xHx (Ln = La, Sm) under pressure by means of x-ray absorption spectroscopy (XAS), x-ray emission spectroscopy (XES), and x-ray diffraction. In LaFeAsO the pre-edge peak on high-resolution XAS at the Fe-K absorption edge gains in intensity on the application of pressure up to 5.7 GPa and it saturates in the higher pressure region. We found integrated-absolute difference values on XES for Ln = La, corresponding to a spin state, decline on the application of pressure, and then it is minimized when the Tc approaches the maximum at around 5 GPa. In contrast, such the optimum value was not detected for Ln = Sm. We reveal that the superconductivity is closely related to the lower spin state for Ln = La unlike Sm case. We observed that As height from the Fe basal plane and As-Fe-As angle on the FeAs4 tetrahedron for Ln = La deviate from the optimum values of the regular tetrahedron in superconducting (SC) phase, which has been widely accepted structural guide to SC thus far. In contrast, the structural parameters were held near the optimum values up to ∼15 GPa for Ln = Sm.

Published
2021

78. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction: II pressure dependence.

Author

Yamamoto, Yoshiya, Yamaoka, Hitoshi, Kawai, Takuma, Yoshida, Masahiro, Yamaura, Jun-ichi, Ishii, Kenji, Onari, Seiichiro, Uozumi, Takayuki, Hariki, Atsushi, Taguchi, Munetaka, Kobayashi, Kensuke, Lin, Jung-Fu, Hiraoka, Nozomu, Ishii, Hirofumi, Tsuei, Ku-Ding, Okanishi, Hiroshi, Iimura, Soshi, Matsuishi, Satoru, Hosono, Hideo, and Mizuki, Jun'ichiro

Published
2021
Full Text
View/download PDF

79. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction (part I: carrier-doping dependence).

Author

Yamamoto, Yoshiya, Yamaoka, Hitoshi, Uozumi, Takayuki, Hariki, Atsushi, Onari, Seiichiro, Yamaura, Jun-ichi, Ishii, Kenji, Kawai, Takuma, Yoshida, Masahiro, Taguchi, Munetaka, Kobayashi, Kensuke, Lin, Jung-Fu, Hiraoka, Nozomu, Ishii, Hirofumi, Tsuei, Ku-Ding, Okanishi, Hiroshi, Iimura, Soshi, Matsuishi, Satoru, Hosono, Hideo, and Mizuki, Jun'ichiro

Published
2021
Full Text
View/download PDF

81. Study of the Pressure-Induced Second Superconducting Phase of (NH3)yCs0.4FeSe with Double-Dome Superconductivity

Author

Yamamoto, Yoshiya, primary, Yamaoka, Hitoshi, additional, Onari, Seiichiro, additional, Yoshida, Masahiro, additional, Hirao, Naohisa, additional, Kawaguchi, Saori, additional, Oishi, Yasuo, additional, Miao, Xiao, additional, Kubozono, Yoshihiro, additional, Lin, Jung-Fu, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Liao, Yen-Fa, additional, Tsuei, Ku-Ding, additional, and Mizuki, Jun’ichiro, additional

Published
2019
Full Text
View/download PDF

83. Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting

Author

Sho, Takuya, primary, Suda, Goki, additional, Ogawa, Koji, additional, Kimura, Megumi, additional, Shimazaki, Tomoe, additional, Maehara, Osamu, additional, Shigesawa, Taku, additional, Suzuki, Kazuharu, additional, Nakamura, Akihisa, additional, Ohara, Masatsugu, additional, Umemura, Machiko, additional, Kawagishi, Naoki, additional, Natsuizaka, Mitsuteru, additional, Nakai, Masato, additional, Morikawa, Kenichi, additional, Furuya, Ken, additional, Baba, Masaru, additional, Yamamoto, Yoshiya, additional, Kobayashi, Tomoe, additional, Meguro, Takashi, additional, Saga, Akiyoshi, additional, Miyagishima, Takuto, additional, Yokoo, Hideki, additional, Kamiyama, Toshiya, additional, Taketomi, Akinobu, additional, and Sakamoto, Naoya, additional

Published
2019
Full Text
View/download PDF

84. Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.

Author

Suzuki, Kazuharu, Suda, Goki, Yamamoto, Yoshiya, Furuya, Ken, Baba, Masaru, Nakamura, Akinobu, Miyoshi, Hideaki, Kimura, Megumi, Maehara, Osamu, Yamada, Ren, Kitagataya, Takashi, Yamamoto, Koji, Shigesawa, Taku, Nakamura, Akihisa, Ohara, Masatsugu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, and Morikawa, Kenichi

Subjects
LIPID metabolism, HEPATITIS B virus, VIRUS diseases, BLOOD cholesterol, DYSLIPIDEMIA, PROPENSITY score matching, CHRONIC hepatitis B
Abstract

Background: Entecavir and tenofovir–disoproxil–fumarate are first-line nucleos(t)ide analogs (NA) for treatment of hepatitis B virus (HBV) infections; however, their long-term administration can impact extrahepatic organs. Herein, we sought to examine the effect of NA on lipid metabolism while also characterizing the associated mechanism. Methods: A retrospective study was performed on HBV patients administered entecavir or tenofovir–disoproxil–fumarate. Patient clinical information, as well as their preserved serum samples obtained at baseline and 6–12 months after treatment initiation, were analyzed. A 1:1 propensity score matching was applied to the assignment of tenofovir–disoproxil–fumarate or entecavir treatment. Changes in serum cholesterol, including oxidized-LDL, were analyzed. Subsequently, in vitro analysis elucidated the mechanism associated with the effect of NAs on lipid metabolism. Results: Administration of tenofovir–disoproxil–fumarate, not entecavir, to chronic HBV patients, decreased serum cholesterol levels, including non-HDL and oxidized-LDL, which are strongly associated with arteriosclerosis. In vitro analysis revealed that tenofovir–disoproxil–fumarate reduced supernatant cholesterol, and upregulated the scavenger receptor, CD36, in hepatocytes. Meanwhile, silencing of hepatic CD36 increased supernatant cholesterol and negated the cholesterol-reducing effect of tenofovir–disoproxil–fumarate in HepG2-cells. Reporter, microarray, and RT-PCR analyses further revealed that tenofovir–disoproxil–fumarate treatment activates PPAR-α-mediated signaling, and upregulates PPAR-α target genes, including CPT1 and CD36. Alternatively, silencing of PPAR-α reversed the effects of tenofovir–disoproxil–fumarate on CD36. Conclusions: Tenofovir–disoproxil–fumarate modulates lipid metabolism by upregulating hepatic CD36 via PPAR-α activation. Since dyslipidemia could be associated with arteriosclerosis and hepatocarcinogenesis, these discoveries provide novel insights into anti-HBV therapies, as well as the associated extrahepatic effects of NA. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

85. Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.

Author

Sho, Takuya, Suda, Goki, Ogawa, Koji, Kimura, Megumi, Shimazaki, Tomoe, Maehara, Osamu, Shigesawa, Taku, Suzuki, Kazuharu, Nakamura, Akihisa, Ohara, Masatsugu, Umemura, Machiko, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken, Baba, Masaru, Yamamoto, Yoshiya, Kobayashi, Tomoe, and Meguro, Takashi

Subjects
LIVER cancer, CANCER chemotherapy, CLINICAL trials
Abstract

Background and Aim: Lenvatinib has been recently approved as a first‐line systematic therapy for patients with advanced hepatocellular carcinoma (HCC) based on the results of the phase 3 clinical trial REFLECT. This trial excluded patients with a history of systemic chemotherapy, bile duct invasion, and Child‐Pugh grade B. We aimed to investigate the efficacy and safety of lenvatinib for these patients and in the real‐world setting. Methods: Among patients who were administered lenvatinib for advanced HCC between April and October 2018 in Hokkaido University Hospital and related hospitals, we evaluated those who were followed for more than 2 months and whose treatment response was evaluated via dynamic computed tomography at baseline and 2 months after treatment initiation. Meanwhile, patients were excluded if they had decompensated liver cirrhosis, were followed up less than 2 months, or were not evaluated at 2 months. Patients were also stratified according to compliance with the REFLECT inclusion criteria for further analysis. Results: A total of 41 patients were included; more than 50% did not meet the REFLECT inclusion criteria. In total, 5 (12.2%), 20 (48.8%), 12 (29.3%), and 4 (9.3%) showed complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate was 61.2%. The objective response rate and disease control rate were similar between patients who did and did not meet the REFLECT inclusion criteria. Moreover, the safety profile was also similar between the two patient groups. Conclusion: Lenvatinib showed high early response rate and tolerability in patients with advanced HCC. Favorable outcomes were similarly observed in patients who did not meet the REFLECT inclusion criteria. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

86. Mössbauer Spectroscopy Study of KxFe2−ySe2 under Pressure.

Author

Yamamoto, Yoshiya, Mitsui, Takaya, Kitao, Shinji, Seto, Makoto, Mizobata, Naoyuki, Ozaki, Toshinori, Yamaoka, Hitoshi, and Mizuki, Jun'ichiro

Abstract

A Mössbauer spectroscopy study of the iron-based superconductor KxFe2−ySe2, with two superconducting phases of SC1 and a pressure induced SC2 was performed under pressure. This compound consists of two separated phases of major magnetic (non-superconducting) and minor superconducting components. The internal magnetic field of the major magnetic component decreased at the SC2 phase and disappeared around 15 GPa, while that of the minor non-magnetic component maintained its intensity up to 14.9 GPa. Multiple internal magnetic fields were introduced for improved fits to the spectra of the magnetic component at the SC2 phase, suggesting the importance of the electron–electron correlation in the emergence of the SC2 phase. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

87. Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.

Author

Suzuki, Kazuharu, Suda, Goki, Yamamoto, Yoshiya, Furuya, Ken, Baba, Masaru, Kimura, Megumi, Maehara, Osamu, Shimazaki, Tomoe, Yamamoto, Koji, Shigesawa, Taku, Nakamura, Akihisa, Ohara, Masatsugu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, and Sakamoto, Naoya

Subjects
CHRONIC hepatitis B, HEPATITIS B, HEPATITIS B virus, ALANINE aminotransferase, GLOMERULAR filtration rate, CHRONIC kidney failure
Abstract

Aim: Entecavir (ETV), tenofovir disoproxil fumarate (TDF), and tenofovir alafenamide (TAF) are first‐line nucleos(t)ide analogues for hepatitis B virus (HBV)‐infected patients. However, consecutive TDF treatment causes renal dysfunction, and the safety and efficacy of TAF have not been established in severe renal dysfunction patients, including hemodialysis patients. The efficacy and safety of ETV in these populations has not been clarified. The study aimed to clarify this. Methods: In this retrospective multicenter study, between 2006 and 2018, a total of 567 HBV‐infected patients treated with ETV monotherapy were screened. Patients were included if >20 years old, treated with ETV monotherapy for >1 year, and had proper clinical information. The efficacy of ETV and changes in renal function were evaluated according to renal function. Results: A total of 273 patients were included: 9.2% (25/273), 1.8% (5/273), and 3.7% (10/273) had chronic kidney disease (CKD) stage G3, CKD stage G4/5, and were on hemodialysis, respectively. Overall, 84.2%, 94.0%, and 96.2% of patients experienced serum HBV‐DNA disappearance at 1, 2, and 3 years, respectively, after treatment initiation. In patients with CKD stage G3–5, estimated glomerular filtration rate tended to restore with time, which was in contrast to patients without renal dysfunction. The rate of disappearance in serum HBV‐DNA, alanine transaminase normalization, and virological breakthrough was similar between patients with or without renal dysfunction. ETV showed high efficacy for all 10 hemodialysis patients without virological breakthrough. Conclusions: Entecavir for HBV‐infected patients with severe renal dysfunction, including hemodialysis patients, is highly effective and does not affect renal function. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

88. Reentrant valence transition in YbCu4.5 under pressure

Author

Yamaoka, Hitoshi, primary, Tsujii, Naohito, additional, Yamamoto, Yoshiya, additional, Michiue, Yuichi, additional, Lin, Jung-Fu, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, and Mizuki, Jun'ichiro, additional

Published
2018
Full Text
View/download PDF

89. HCV Infection on Lymphoid Neoplasm

Author

Tsutsumi, Yutaka, primary, Yamamoto, Yoshiya, additional, Ito, Shinichi, additional, Sekine, Takahiro, additional, Matsuoka, Satomi, additional, Naruse, Hirohito, additional, and Teshima, Takanori, additional

Published
2018
Full Text
View/download PDF

90. Electronic structure of ferromagnetic heavy fermion, YbPdSi, YbPdGe, and YbPtGe studied by photoelectron spectroscopy, x-ray emission spectroscopy, and DFT + DMFT calculations

Author

Yamaoka, Hitoshi, primary, Thunström, Patrik, additional, Tsujii, Naohito, additional, Katoh, Kenichi, additional, Yamamoto, Yoshiya, additional, Schwier, Eike F, additional, Shimada, Kenya, additional, Iwasawa, Hideaki, additional, Arita, Masashi, additional, Jarrige, Ignace, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, and Mizuki, Jun’ichiro, additional

Published
2017
Full Text
View/download PDF

92. Observation of momentum-dependent charge excitations in hole-doped cuprates using resonant inelastic x-ray scattering at the oxygen K edge

Author

Ishii, Kenji, primary, Tohyama, Takami, additional, Asano, Shun, additional, Sato, Kentaro, additional, Fujita, Masaki, additional, Wakimoto, Shuichi, additional, Tustsui, Kenji, additional, Sota, Shigetoshi, additional, Miyawaki, Jun, additional, Niwa, Hideharu, additional, Harada, Yoshihisa, additional, Pelliciari, Jonathan, additional, Huang, Yaobo, additional, Schmitt, Thorsten, additional, Yamamoto, Yoshiya, additional, and Mizuki, Jun'ichiro, additional

Published
2017
Full Text
View/download PDF

93. Electronic structures and spin states of BaFe2As2 and SrFe2As2 probed by x-ray emission spectroscopy at Fe and As K -absorption edges

Author

Yamaoka, Hitoshi, primary, Yamamoto, Yoshiya, additional, Lin, Jung-Fu, additional, Wu, Junjie J., additional, Wang, Xiancheng, additional, Jin, Changqing, additional, Yoshida, Masahiro, additional, Onari, Seiichiro, additional, Ishida, Shigeyuki, additional, Tsuchiya, Yoshinori, additional, Takeshita, Nao, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, Chow, Paul, additional, Xiao, Yuming, additional, and Mizuki, Jun'ichiro, additional

Published
2017
Full Text
View/download PDF

94. Response to letter regarding article, “The prognostic impact of uric acid in patients with severely decompensated acute heart failure”

Author

Okazaki, Hirotake, primary, Shirakabe, Akihiro, additional, Otsuka, Toshiaki, additional, Kobayashi, Nobuaki, additional, Hata, Noritake, additional, Shinada, Takuro, additional, Matsushita, Masato, additional, Yamamoto, Yoshiya, additional, Shibuya, Junsuke, additional, Shiomura, Reiko, additional, Nishigoori, Suguru, additional, Asai, Kuniya, additional, and Shimizu, Wataru, additional

Published
2017
Full Text
View/download PDF

95. Pressure-induced anomalous valence crossover in cubic YbCu5-based compounds

Author

Yamaoka, Hitoshi, primary, Tsujii, Naohito, additional, Suzuki, Michi-To, additional, Yamamoto, Yoshiya, additional, Jarrige, Ignace, additional, Sato, Hitoshi, additional, Lin, Jung-Fu, additional, Mito, Takeshi, additional, Mizuki, Jun’ichiro, additional, Sakurai, Hiroya, additional, Sakai, Osamu, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, Giovannini, Mauro, additional, and Bauer, Ernst, additional

Published
2017
Full Text
View/download PDF

96. Usefulness of the Direct and/or Total Bilirubin to Predict Adverse Outcomes in Patients With Acute Decompensated Heart Failure

Author

Okada, Atsushi, primary, Sugano, Yasuo, additional, Nagai, Toshiyuki, additional, Honda, Yasuyuki, additional, Iwakami, Naotsugu, additional, Nakano, Hiroki, additional, Takashio, Seiji, additional, Honda, Satoshi, additional, Asaumi, Yasuhide, additional, Aiba, Takeshi, additional, Noguchi, Teruo, additional, Kusano, Kengo, additional, Yasuda, Satoshi, additional, Anzai, Toshihisa, additional, Kawakami, Shoji, additional, Yamamoto, Yoshiya, additional, Yamamoto, Masahiro, additional, Motokawa, Tetsufumi, additional, Hamatani, Yasuhiro, additional, Shibata, Tatsuhiro, additional, Homma, Takehiro, additional, Chinen, Daigo, additional, Yamane, Takafumi, additional, Yoshida, Chinatsu, additional, Ogura, Sachiko, additional, Maruta, Akiko, additional, and Sumita, Yoko, additional

Published
2017
Full Text
View/download PDF

97. Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

Author

Suda, Goki, primary, Furusyo, Norihiro, additional, Toyoda, Hidenori, additional, Kawakami, Yoshiiku, additional, Ikeda, Hiroki, additional, Suzuki, Michihiro, additional, Arataki, Keiko, additional, Mori, Nami, additional, Tsuji, Keiji, additional, Katamura, Yoshio, additional, Takaguchi, Koichi, additional, Ishikawa, Toru, additional, Tsuji, Kunihiko, additional, Shimada, Noritomo, additional, Hiraoka, Atsushi, additional, Yamsaki, Sho, additional, Nakai, Masato, additional, Sho, Takuya, additional, Morikawa, Kenichi, additional, Ogawa, Koji, additional, Kudo, Mineo, additional, Nagasaka, Atsushi, additional, Furuya, Ken, additional, Yamamoto, Yoshiya, additional, Kato, Kanji, additional, Ueno, Yoshiyuki, additional, Iio, Etsuko, additional, Tanaka, Yasuhito, additional, Kurosaki, Masayuki, additional, Kumada, Takashi, additional, Chayama, Kazuaki, additional, and Sakamoto, Naoya, additional

Published
2017
Full Text
View/download PDF

98. The prognostic impact of uric acid in patients with severely decompensated acute heart failure

Author

Okazaki, Hirotake, primary, Shirakabe, Akihiro, additional, Kobayashi, Nobuaki, additional, Hata, Noritake, additional, Shinada, Takuro, additional, Matsushita, Masato, additional, Yamamoto, Yoshiya, additional, Shibuya, Junsuke, additional, Shiomura, Reiko, additional, Nishigoori, Suguru, additional, Asai, Kuniya, additional, and Shimizu, Wataru, additional

Published
2016
Full Text
View/download PDF

99. Pressure-induced phase transition in LaCo5 studied by x-ray emission spectroscopy, x-ray diffraction, and density functional theory

Author

Yamaoka, Hitoshi, primary, Yamamoto, Yoshiya, additional, Schwier, Eike F., additional, Tsujii, Naohito, additional, Yoshida, Masahiro, additional, Ohta, Yu, additional, Sakurai, Hiroya, additional, Lin, Jung-Fu, additional, Hiraoka, Nozomu, additional, Ishii, Hirofumi, additional, Tsuei, Ku-Ding, additional, Arita, Masashi, additional, Shimada, Kenya, additional, and Mizuki, Jun'ichiro, additional

Published
2016
Full Text
View/download PDF

100. Association between the body mass index and the clinical findings in patients with acute heart failure: evaluation of the obesity paradox in patients with severely decompensated acute heart failure

Author

Matsushita, Masato, primary, Shirakabe, Akihiro, additional, Hata, Noritake, additional, Shinada, Takuro, additional, Kobayashi, Nobuaki, additional, Tomita, Kazunori, additional, Tsurumi, Masafumi, additional, Okazaki, Hirotake, additional, Yamamoto, Yoshiya, additional, Asai, Kuniya, additional, and Shimizu, Wataru, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results